Stryker has signed an agreement to acquire US medical technology firm Entellus Medical for around $662m.
The company’s ENT product portfolio includes XprESS multi-sinus dilation system, Latera absorbable nasal implant, MiniFESS surgical instruments, XeroGel nasal dressing and FocESS imaging and navigation solutions.
In July this year, Entellus Medical agreed to acquire US ENT medical technology firm Spirox for around $81m.
Based in Redwood City of California, Spirox develops, produces, and markets Latera absorbable nasal implant, which is an invasive option for ENTs and facial plastic surgeons to treat nasal airway obstruction.
Stryker MedSurg and Neurotechnology group president Timothy Scannell said: “Entellus is a leader in the ENT segment and offers a comprehensive portfolio of products that enable physicians to conveniently and comfortably perform a broad range of ENT procedures.”
Entellus CEO Robert White said: “The combination of Stryker’s established commitment to making healthcare better and Entellus’ innovative products within the ENT segment will continue to provide our customers the tools they need for cost effective solutions.”
In September 2016, Stryker acquired US-based orthopedic device company Ivy Sports Medicine for an undisclosed sum.
Ivy Sports Medicine is engaged in the development, manufacturing and marketing of tissue growth and repair products that focus on preservation of the meniscus.
Stryker provides products and services in different specialties, including orthopaedics, medical and surgical, and neurotechnology and spine.
Image: Stryker to acquire medical technology firm Entellus Medical. Photo: courtesy of adamr / FreeDigitalPhotos.net.